Investors high on Oncimmune distribution deal
AIM-listed cancer immunodiagnostics firm Oncimmune Holdings has announced a US distribution agreement for two of its blood test products
AIM-listed cancer immunodiagnostics firm Oncimmune Holdings has announced a US distribution agreement for two of its blood test products
China Special Situations has suffered as a result of the trade war tensions but could be a good one for adventurous, contrarian investors.
The price of shares in AIM-listed Velocys have risen by 13.01% to 4.57p after it acquired a site for a UK waste-to-jet fuel project.
The prices of shares in GlaxoSmithKline has risen by 7.62% after the company announced that it would form a consumer healthcare joint venture with Pfizer.
Online gambling operator 888 Holdings has confirmed that EBITDA for the year ending 31st December will be in line with expectations.
Inside the mind of the Master Investor: UK billionaire investor Jim Mellon reveals his trading and investing strategy for 2019.
Telit Communications has seen its share price drop after the Financial Conduct Authority widened its investigation into the company’s activities.
AIM-listed power storage firm Redt Energy announced that the financial close of the first part of its German portfolio would be delayed into the New Year.
Petrofac said that trading in the year ending 31st December was in line with expectations, with more than $5 billion in new orders received in the period.
Simon Cawkwell, AKA Evil Knievil, with his latest trading and gambling exploits – writing exclusively for Master Investor.